Alzheimer's Disease Trial, Not Yet Recruiting NCT06894953 Sponsor: University of Strathclyde Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT06894953
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • A doctor has diagnosed the person with probable Alzheimer's disease of mild to moderate severity, based on recognised medical diagnostic guidelines.
  • The person is aged 50 or older.
  • The person has adequate vision, hearing, language, and physical ability to complete study assessments (hearing aids and glasses are allowed).
  • The person scores between 20 and 82 on a cognitive test called the ACE III, or an equivalent score on similar tests (the MMSE or MoCA).
  • The person has a caregiver or family member who is able to attend all study visits, help with assessments, and supervise the taking of the study treatment.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • Medical records show the person has a visual variant of Alzheimer's disease or a colour vision problem.
  • Medical records show a brain scan (CT or MRI) done within the past 24 months that points to a diagnosis other than probable Alzheimer's disease.
  • Medical records show any significant brain or nervous system condition other than probable Alzheimer's disease, such as Parkinson's disease, Huntington's disease, brain tumour, a history of stroke, seizures, multiple sclerosis, or a past head injury that required hospitalisation.
  • Medical records show clinically significant abnormal findings from a past physical examination, medical history, or lab results that suggest a different diagnosis (confirm with trial site).
  • Medical records show a current history of a major psychiatric condition, such as major depression.
  • Medical records show a history of substance misuse.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
University of Strathclyde
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
28 February 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Quality of autobiographical memory during AMPER use; Autobiographical Memory ability (objectively rated); Autobiographical Memory ability (subjectively rated); Autobiographical Memory ability (subjectively rated on SAM)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov